RE:RE:Be careful, often goes up a little before earningsi guess chart dosent lie
although i would have to say that all Pot stocks had a great day so i would say that this particular rise in SP is something other than a pre earnings rise ...i beleve its the fact that a major market in Europe..Germany.. is days away from leagalized (medical use Canabis)
lets hope we get another good bump from Q4 numbers realease as well as a substantive projection from management regarding 2024 earnings they would have a good sense of orders and inquiry regarding products from Germany and possibly Brazil !!??
just hope they arent shy when it comes to sharing that info.
Medical Cannabis - Germany
- In Germany, the Medical Cannabis market is anticipated to witness a substantial growth in revenue, with projections estimating it to reach US$395.80m by the year 2024.
- Moreover, the market is expected to display a steady annual growth rate (CAGR 2024-2028) of 12.77%, resulting in a significant expansion of the market volume to US$640.20m by 2028.
- When compared on a global scale, in the United States is predicted to generate the highest revenue in the Medical Cannabis market, with a staggering US$13,110.00m in 2024.
- This showcases the dominance of the United States in this market segment.
- To provide a perspective on the revenue generated per person, it is estimated that in Germany, each individual will contribute US$4.76 in revenue in 2024.
- This figure gives us an understanding of the economic impact of the Medical Cannabis market on the population as a whole.
- Germany's medical cannabis market is experiencing significant growth due to increasing patient demand and favorable government regulations.